Yttrium-90 (Y-90)

Yttrium-90 (Y-90) is a radioactive isotope used in targeted cancer treatments, especially for liver tumors. It emits beta particles that destroy cancer cells while minimizing damage to surrounding healthy tissue. Y-90 is typically delivered directly into blood vessels feeding the tumor through a procedure called radioembolization. Its radioactivity gradually decreases over time, reducing long-term risks. This precision approach allows for effective tumor treatment with fewer side effects compared to traditional methods like surgery or radiation, making Y-90 a valuable option in cancer therapy.